Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access | SpringerLink

"Beginning with the January 2024 issue, Neurotherapeutics will become a fully Open Access journal in keeping with the overall trend in scientific publishing. Over the years, the official journal of the American Society for Experimental Neurotherapeutics (ASENT) has gone through a number of transitions regarding its publishing model, beginning with traditional subscription-based print journal paid by libraries, universities, and other institutions, then hybrid online publishing with both subscription and open access options, and now moving to fully open access where the cost of publishing will be covered by authors, their funders, or institutions. Invited articles will not be subject to Article Processing Charges. Along with this change, Elsevier will now be the new publisher of Neurotherapeutics."